Potential role of IgM-enriched immunoglobulin as adjuvant treatment for invasive meningococcal disease

被引：6
|
作者：
Tascini, Carlo [1 ]
Fraganza, Fiorentino [2 ]
Salani, Francesca [3 ]
Sozio, Emanuela [4 ]
Rossi, Marco [1 ]
Sbrana, Francesco [5 ]
Carannante, Novella [1 ]
Chiesa, Maria Daniela [2 ]
Ripoli, Andrea [5 ]
Bertolino, Giacomo [6 ]
Di Pietro, Massimo [7 ]
Bartoloni, Alessandro [8 ,9 ]
Menichetti, Francesco [3 ]
机构：
[1] Azienda Osped Colli, Cotugno Hosp, Div Infect Dis 1, Naples, Italy
[2] Azienda Osped Colli, Intens Care Unit, Cotugno Hosp, Naples, Italy
[3] Azienda Osped Univ Pisana, Nuovo Santa Chiara Univ Hosp, Infect Dis Clin, Pisa, Italy
[4] Azienda Osped Univ Pisana, Emergency Med Unit, Nuovo Santa Chiara Univ Hosp, Pisa, Italy
[5] Fdn Toscana Gabriele Monasterio, Pisa, Italy
[6] Azienda Osped Univ Pisana, Dept Pharmaceut, Pisa, Italy
[7] Cent Tuscany Hlth Author, S Maria Annunziata Hosp, Infect Dis Unit, Florence, Italy
[8] Careggi Univ Hosp, Infect & Trop Dis Unit, Florence, Italy
[9] Univ Florence, Dept Expt & Clin Med, Florence, Italy
来源：
INTENSIVE CARE MEDICINE | 2018年 / 44卷 / 02期
关键词：
INTRAVENOUS IMMUNOGLOBULIN;
D O I：
10.1007/s00134-017-4957-z
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：261 / 262
页数：2
相关论文
共 50 条
  • [31] The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis: another point of view
    Karatzas, S
    Boutzouka, E
    Venetsanou, K
    Myrianthefs, P
    Fildisis, G
    Baltopoulos, G
    CRITICAL CARE, 2002, 6 (06): : 543 - 544
  • [32] Number needed to treat and cost per life saved of adjunctive igm-enriched immunoglobulin treatment of sepsis in Germany
    Barlozek, M.
    Nowak, A.
    Ruebesam, T.
    Gockel, U.
    INFECTION, 2017, 45 : S45 - S45
  • [33] The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis: another point of view
    Stylianos Karatzas
    Eleni Boutzouka
    Kyriaki Venetsanou
    Pavlos Myrianthefs
    George Fildisis
    George Baltopoulos
    Critical Care, 6
  • [34] Effects of IgM-enriched immunoglobulin and fluid replacement on nerve conduction velocity in experimental sepsis
    Cankayali, Ilkin
    Dogan, Yusuf Hakan
    Solak, Ilhami
    Eris, Oguz
    Demirgoren, Serdar
    Moral, Ali Resat
    ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY, 2010, 16 (01): : 9 - 14
  • [35] The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis [ISRCTN28863830]
    Simru Tugrul
    Perihan Ergin Ozcan
    Ozkan Akinci
    Yalcin Seyhun
    Atahan Cagatay
    Nahit Cakar
    Figen Esen
    Critical Care, 6
  • [36] Adjuvant therapy of mediastinitis with IgM-enriched immunoglobulins (ATMI) - A multicenter, randomized controlled trial
    Marggraf, G
    Lefering, R
    Thielmann, M
    Struff, W
    Neugebauer, E
    Jakob, H
    CHEST, 2004, 126 (04) : 861S - 861S
  • [37] Treatment of donor-specific antibody-mediated rejection after heart transplantation by IgM-enriched human immunoglobulin
    Immohr, Moritz Benjamin
    Akhyari, Payam
    Aubin, Hug
    Westenfeld, Ralf
    Mehdiani, Arash
    Bruno, Raphael Romano
    Sipahi, Nihat Firat
    Erbel-Khurtsidze, Sophiko
    Reinecke, Petra
    Tudorache, Igor
    Lichtenberg, Artur
    Boeken, Udo
    ESC HEART FAILURE, 2021, 8 (04): : 3413 - 3417
  • [38] Efficacy of IgM-enriched Immunoglobulin for Vasopressor-resistant Vasoplegic Shock After Liver Transplantation
    Willuweit, Katharina
    Bezinover, Dmitri
    Herzer, Kerstin
    Nowak, Knut M.
    Paul, Andreas
    Saner, Fuat H.
    TRANSPLANTATION, 2019, 103 (02) : 381 - 386
  • [39] Treatment of Donor-Specific Antibody Mediated Rejection after Heart Transplantation by IGM-Enriched Human Intravenous Immunoglobulin
    Immohr, M. B.
    Aubin, H.
    Westenfeld, R.
    Mehdiani, A.
    Scheiber, D.
    Bruno, R.
    Tudorache, I.
    Akhyari, P.
    Lichtenberg, A.
    Boeken, U.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S295 - S295
  • [40] IGM-ENRICHED HUMAN INTRAVENOUS IMMUNOGLOBULIN (IGGAM) FOR TREATMENT OF EARLY ANTIBODY MEDIATED REJECTION (AMR) AFTER HEART TRANSPLANTATION (HTX)
    Barten, M.
    Buchholz, C.
    Bernhardt, A.
    Grahn, H.
    Rybczynski, M.
    Reichenspurner, H.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 39 - 39
12345